These findings suggest that BYL-719 effectively suppresses the paracrine effects of Mac-ADSCs, suggesting a potential therapeutic strategy for treating macrodactyly and other PIK3CA-related overgrowth conditions. This evidence concerns the gene PIK3CA and megalodactyly.